These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 3323562

  • 1. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
    Shikano M, Ito T, Ogawa K, Satake T.
    Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
    [Abstract] [Full Text] [Related]

  • 2. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O, Nagatsuka K, Nakabayashi S, Isaka Y, Yoneda S, Kimura K, Abe H.
    Stroke; 1985 Sep; 16(2):241-4. PubMed ID: 3883580
    [Abstract] [Full Text] [Related]

  • 3. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
    Shikano M, Ogawa K, Ito T, Chen LS, Ito Y, Imaizumi M, Uno T, Tsutsumi S, Satake T.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Sep; 13():375-7. PubMed ID: 3159226
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y, Hattori R, Takatsu Y, Nakajima H, Wakabayashi A, Kawai C, Kayama N, Hiraku S, Inagawa T, Tsubojima M.
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs.
    Ishihara Y, Uchida Y, Kitamura S.
    Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388
    [Abstract] [Full Text] [Related]

  • 7. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H, Hirai A, Terano T, Tamura Y, Yoshida S.
    Thromb Haemost; 1993 Mar 01; 69(3):276-81. PubMed ID: 8470052
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC, Fletcher JR, Zmudka MI, Ramwell PW.
    J Pharmacol Exp Ther; 1982 Aug 01; 222(2):441-6. PubMed ID: 6896528
    [Abstract] [Full Text] [Related]

  • 10. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
    Gomi T, Ikeda T, Ishimitsu T, Uehara Y.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep 01; 37(3):139-44. PubMed ID: 2608692
    [Abstract] [Full Text] [Related]

  • 11. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
    Ohnishi A, Ishizaki T, Echizen H, Yasuda K, Fujiwara H, Tanaka T.
    Clin Pharmacol Ther; 1992 Apr 01; 51(4):454-64. PubMed ID: 1563215
    [Abstract] [Full Text] [Related]

  • 12. Changes of plasma 6-keto-PGF1 alpha and thromboxane B2 levels and platelet aggregation after tourniquet ischemia on the upper limb in normal subjects and patients with ischemic heart disease.
    Chen LS, Ito T, Ogawa K, Satake T.
    Jpn Circ J; 1982 Jul 01; 46(7):651-6. PubMed ID: 6896534
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
    Mehta J, Mehta P, Ostrowski N.
    Prostaglandins Leukot Med; 1983 Sep 01; 12(1):49-52. PubMed ID: 6356153
    [Abstract] [Full Text] [Related]

  • 14. The significance of platelet-vessel wall prostaglandin equilibrium during exercise-induced stress.
    Mehta J, Mehta P, Horalek C.
    Am Heart J; 1983 Jun 01; 105(6):895-900. PubMed ID: 6344604
    [Abstract] [Full Text] [Related]

  • 15. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep.
    Kubo K, Kobayashi T.
    Am Rev Respir Dis; 1985 Sep 01; 132(3):494-9. PubMed ID: 3898941
    [Abstract] [Full Text] [Related]

  • 16. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
    Kuzuya T, Hoshida S, Yamagishi M, Ohmori M, Inoue M, Kamada T, Tada M.
    Jpn Circ J; 1986 Nov 01; 50(11):1071-8. PubMed ID: 3102802
    [Abstract] [Full Text] [Related]

  • 17. In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.
    Davenport NJ, Goldstein RE, Feuerstein GZ.
    J Cardiovasc Pharmacol; 1991 Apr 01; 17(4):641-6. PubMed ID: 1711633
    [Abstract] [Full Text] [Related]

  • 18. Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion.
    Austin JC, Berrizbeitia LD, Schoen FJ, Kauffman RP, Hechtman HB, Cohn LH.
    Am Heart J; 1988 Mar 01; 115(3):505-9. PubMed ID: 3344655
    [Abstract] [Full Text] [Related]

  • 19. Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death.
    Edmonds LC, Lefer AM.
    Life Sci; 1984 Oct 22; 35(17):1763-8. PubMed ID: 6434893
    [Abstract] [Full Text] [Related]

  • 20. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin.
    Nagatsuka K, Uyama O, Nakabayashi S, Yoneda S, Kimura K, Kamada T.
    Stroke; 1985 Oct 22; 16(5):806-9. PubMed ID: 3931302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.